The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) evaluated Moderna’s COVID-19 vaccine as highly effective with a favorable safety profile, based on interim data from an ongoing phase 3 trial. The panel acknowledged that further studies will be required post issuance of an Emergency Use Authorization (EUA) to collect additional data on
Pfizer’s Covid-19 vaccine is pictured at Rady Children’s Hospital before it’s placed back in the refrigerator in San Diego, California on December 15, 2020. Adriana Drehsler | AFP | Getty Images Doses of the coronavirus vaccine may have been wrongfully obtained and distributed throughout parts of New York, the state’s top doctor said Saturday. Dr.
Print this page PLYMOUTH MEETING, Pa., Sept. 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it has additional questions about the company’s